-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on March 17th.
These consumables have dropped to the lowest price in the country.
Recently, the Zhejiang Pharmaceutical
Equipment Procurement Platform issued a notice on the implementation of the first batch of "Zhejiang Medical Consumables Centralized Procurement Product Dynamic Adjustment and Reform Plan" product registration and other matters
.
The above notice shows that the dynamic adjustment of medical consumables within the scope of centralized procurement is carried out in different categories and batches.
According to the sorting of Cyblan Instruments, the first batches are cardiac (coronary artery) interventional, peripheral vascular interventional, cardiac pacemaker, and electrical Physiological medical consumables are classified according to the secondary catalog, specifically involving 245 medical consumables
.
It is understood that on February 9, the Zhejiang Provincial Medical Insurance Bureau issued the "Notice on Printing and Distributing the Dynamic Adjustment and Reform Plan for Centralized Procurement of Medical Consumables in Zhejiang Province
.
" The implementation scope of the "Notice" covers the medical consumables that belong to the scope of centralized procurement in the Zhejiang Pharmaceutical Equipment Procurement Platform
.
Among them, those belonging to a new secondary catalog or a secondary catalog of products without online trading can be linked to the Internet according to the following pricing principles: It is required to purchase and list the network in a province-based unit (winning the bid) in 10 or more provinces, not higher than the country.
The lowest price; if there are less than 10 , it will not be higher than the negotiated lowest price after negotiating with at least 5 tertiary hospitals in the province, provided that it is not higher than the national lowest price
.
Compared with products that have been traded online in the same second-level catalog (imported and domestically produced, including sets), the prices can be listed on the Internet according to other principles
.
In fact, in addition to Zhejiang, the Sichuan Provincial Medical Insurance Bureau also recently issued the " Implementation Plan for Centralized Procurement of Medical Consumables for Medical Institutions in Sichuan Province ", showing that vascular intervention, non-vascular intervention, orthopedics, neurosurgery, electrophysiology, 10 categories and 39 subcategories of high-value medical consumables, including pacemakers, and 2 categories of low-value medical consumables, as well as all in vitro diagnostic reagents except cleaning fluids, are included in the centralized procurement of medical consumables .
Simultaneously implement quantity procurement and implement price linkage procurement
.
These multinational machinery companies face
price cuts for their products.
It is worth noting that the first batch of price linkages in Zhejiang Province and the above-mentioned price linkages in Sichuan Province all involve electrophysiology and pacemaker consumables
.
According to Eshare Medical Equipment Collection, in cardiac treatment, high-value medical consumables mainly include mapping catheters, ablation catheters, pacemakers, pacing catheters, pacing wires, etc.
According to categories, they can be divided into electrophysiology and pacing Stroke device category
.
The market for electrophysiology and pacemakers should not be underestimated, according to GlobaldaAccording to ta's analysis, the global cardiac rhythm management market is expected to reach approximately US$14.
3 billion in 2018, and it is expected to reach US$15.
7 billion in 2020, with an average annual compound growth rate of 4.
6%
.
Due to the high technical threshold, the market share of high-value medical consumables for electrophysiology and pacemakers in China is mainly concentrated in the hands of a few large import companies (Boston Scientific, St.
Jude, Medtronic, etc.
), and domestic manufacturers have a small share.
Only a few companies are engaged in related fields, and the degree of localization is low
.
Take pacemakers as an example.
According to data from China Industry Information Network, the current listed cardiac pacemakers include single-chamber pacemakers, dual-chamber pacemakers, three-chamber pacemakers, and defibrillators
.
Among them, single-chamber pacemakers can only meet the basic cardiac pacing needs.
The domestic clinical applications of single-chamber pacemakers account for only 30%, and the most important application is dual-chamber pacemakers, which account for about 65% of the market
.
The main manufacturers of single-chamber and dual-chamber pacemakers in China include Qin Ming Medical (Lepu), Medtronic, St.
Jude, Boston Scientific, and Bidori; the main manufacturers of three-chamber pacemakers are Medtronic, Boston Scientific, St.
Jude
.
Information from the Flint Research Institute also shows that from the perspective of manufacturers, the market penetration rate of pacemakers in the domestic market is low and they are mainly monopolized by foreign brands.
The pacemaker brands approved by CFDA include Medtronic, St.
Jude, Boston Scientific, and Baidu.
Doli, Sorin Group, Vitatron, Livetec Ingenieurbüro, etc.
, among which data shows that the top three occupy more than 80% of the market share
.
At present, only Lepu Medical, Lifetech and Chuangling Cardiac Medical have been approved for domestic cardiac pacemakers, and their market share is relatively low
.
These consumables have dropped to the lowest price in the country.
Recently, the Zhejiang Pharmaceutical
Equipment Procurement Platform issued a notice on the implementation of the first batch of "Zhejiang Medical Consumables Centralized Procurement Product Dynamic Adjustment and Reform Plan" product registration and other matters
.
The above notice shows that the dynamic adjustment of medical consumables within the scope of centralized procurement is carried out in different categories and batches.
According to the sorting of Cyblan Instruments, the first batches are cardiac (coronary artery) interventional, peripheral vascular interventional, cardiac pacemaker, and electrical Physiological medical consumables are classified according to the secondary catalog, specifically involving 245 medical consumables
.
It is understood that on February 9, the Zhejiang Provincial Medical Insurance Bureau issued the "Notice on Printing and Distributing the Dynamic Adjustment and Reform Plan for Centralized Procurement of Medical Consumables in Zhejiang Province
.
" The implementation scope of the "Notice" covers the medical consumables that belong to the scope of centralized procurement in the Zhejiang Pharmaceutical Equipment Procurement Platform
.
Among them, those belonging to a new secondary catalog or a secondary catalog of products without online trading can be linked to the Internet according to the following pricing principles: It is required to purchase and list the network in a province-based unit (winning the bid) in 10 or more provinces, not higher than the country.
The lowest price; if there are less than 10 , it will not be higher than the negotiated lowest price after negotiating with at least 5 tertiary hospitals in the province, provided that it is not higher than the national lowest price
.
Compared with products that have been traded online in the same second-level catalog (imported and domestically produced, including sets), the prices can be listed on the Internet according to other principles
.
In fact, in addition to Zhejiang, the Sichuan Provincial Medical Insurance Bureau also recently issued the " Implementation Plan for Centralized Procurement of Medical Consumables for Medical Institutions in Sichuan Province ", showing that vascular intervention, non-vascular intervention, orthopedics, neurosurgery, electrophysiology, 10 categories and 39 subcategories of high-value medical consumables, including pacemakers, and 2 categories of low-value medical consumables, as well as all in vitro diagnostic reagents except cleaning fluids, are included in the centralized procurement of medical consumables .
Simultaneously implement quantity procurement and implement price linkage procurement
.
These multinational machinery companies face
price cuts for their products.
It is worth noting that the first batch of price linkages in Zhejiang Province and the above-mentioned price linkages in Sichuan Province all involve electrophysiology and pacemaker consumables
.
According to Eshare Medical Equipment Collection, in cardiac treatment, high-value medical consumables mainly include mapping catheters, ablation catheters, pacemakers, pacing catheters, pacing wires, etc.
According to categories, they can be divided into electrophysiology and pacing Stroke device category
.
The market for electrophysiology and pacemakers should not be underestimated, according to GlobaldaAccording to ta's analysis, the global cardiac rhythm management market is expected to reach approximately US$14.
3 billion in 2018, and it is expected to reach US$15.
7 billion in 2020, with an average annual compound growth rate of 4.
6%
.
Due to the high technical threshold, the market share of high-value medical consumables for electrophysiology and pacemakers in China is mainly concentrated in the hands of a few large import companies (Boston Scientific, St.
Jude, Medtronic, etc.
), and domestic manufacturers have a small share.
Only a few companies are engaged in related fields, and the degree of localization is low
.
Take pacemakers as an example.
According to data from China Industry Information Network, the current listed cardiac pacemakers include single-chamber pacemakers, dual-chamber pacemakers, three-chamber pacemakers, and defibrillators
.
Among them, single-chamber pacemakers can only meet the basic cardiac pacing needs.
The domestic clinical applications of single-chamber pacemakers account for only 30%, and the most important application is dual-chamber pacemakers, which account for about 65% of the market
.
The main manufacturers of single-chamber and dual-chamber pacemakers in China include Qin Ming Medical (Lepu), Medtronic, St.
Jude, Boston Scientific, and Bidori; the main manufacturers of three-chamber pacemakers are Medtronic, Boston Scientific, St.
Jude
.
Information from the Flint Research Institute also shows that from the perspective of manufacturers, the market penetration rate of pacemakers in the domestic market is low and they are mainly monopolized by foreign brands.
The pacemaker brands approved by CFDA include Medtronic, St.
Jude, Boston Scientific, and Baidu.
Doli, Sorin Group, Vitatron, Livetec Ingenieurbüro, etc.
, among which data shows that the top three occupy more than 80% of the market share
.
At present, only Lepu Medical, Lifetech and Chuangling Cardiac Medical have been approved for domestic cardiac pacemakers, and their market share is relatively low
.